Functional Respiratory Imaging (FRI) quantifies and visualizes the distribution of blood vessels in the lungs in great detail. This simple model, which combines the results of the imaging with the... View Article
The second edition of the Fluidda Magazine on FRI was recently published, containing several articles about how FRI is being used in clinical practice by radiologists and pulmonologists, especially during... View Article
Presentation CEO Fluidda at DDL 2021 conference: Functional Respiratory Imaging in times of COVID19 Tomorrow, December 9, Fluidda’s CEO Jan De Backer will present at the virtual conference Drug delivery... View Article
During the just finished RSNA (Radiological Society of North America) congress, Fluidda introduced its new medical device called Broncholab to the radiologists for the first time. Broncholab is a diagnostic support tool to detect and to improve therapy of... View Article
Fluidda introduces Broncholab application during the RSNA conference, Nov 28 – Dec 2, Chicago Broncholab uses a quantitative imaging tool called Functional Respiratory Imaging (FRI), which gives insights into the... View Article
FRI used to understand the link between pulmonary vasculature abnormalities and DCLO in COVID-19 In a recent article, Prof Daniel Salerno, Prof Victor Kim and colleagues used Functional Respiratory Imaging to better understand the crucial... View Article
In a recent published study Functional Respiratory Imaging (FRI) was used to assess Mandibular advancement devices (MAD) mechanisms. MAD are a non-invasive treatment option for patients with obstructive sleep apnea... View Article
FLUIDDA is the world leader in the field of Functional Respiratory Imaging. This technique combines HRCT scans and Computational Fluid Dynamics technology, enabling the assessment of treatment responses, and helping physicians to make... View Article
A well powered study with FRI as primary endpoint shows the potential of an inhaled P13K delta inhibitor in COPD-exacerbations. A recent paper, published in the Int. Journal of Chronic Obstructive... View Article
Dr. Muhunthan Thillai is a pulmonologist at Cambridge University, specialized in pulmonary fibrosis; and co-founder and CEO of Qur8, an imaging platform for analyzing large clinical sets of data. He is... View Article